2016, under the impetus of countries continue to release favorable policies, domestic medical equipment manufacturers to complete import substitution also gone into the crucial years, the multinational medical device giant is still the biggest rival, they are still firmly in the hands of high-end medical device market. " initiative "; but Yixie domestic enterprises and not far behind, with the" localization strategy started, "the domestic Big Brother Yixie Mindray medical heavy return. Through the ten-year layout, the launch of the domestic A-share listing plan is expected to complete the IPO listing in 2019, which is a battle for the medical equipment field. In addition, what are the hot spots in the medical industry in the near future? The editor of OFweek Medical Network will take you to review it.

　 News review

Look at the bureau of the domestic medical equipment faucet Mindray Medical 10 years ago

In March of this year, Mindray Medical announced that it had completed a $3.3 billion privatization transaction and withdrew from the NYSE. On the eve of the Shanghai Medical Device Exhibition in April, Mindray and Lian Ying reached a strategic cooperation framework agreement. Mindray’s series of actions triggered a big speculation in the industry. What kind of Chinese dream does he have for the return of the king? [ Original reading ]

The ins and outs of a smile from Ronaldo: Rohr has returned more than 2.6 million appreciation to Jinyuan Road

On these two days, an article titled "Luo Yixiao, You Stationed Me" smashed the circle of friends, and also attracted controversy between the public and the author. At the same time, the registered user of the WeChat public account "Rol", Mr. Rolle will give the full appreciation of the article "Luo Yixiao, You Give Me Station", and the appreciation funds of all the articles on the same day of November 30, 2016 will be returned to the original source. Netizen, calculated, totaling 2525808.99 yuan. [ Original reading ]

Fu Yuning leads the China Resources Department and is a strong player in Phoenix Medical

Recently, Phoenix Medical Group released the latest round of appointment and dismissal of board members and senior executives on its official website. China Resources is a strong player. Fu Yuning, Chairman of China Resources Group, is the honorary chairman of Phoenix Medical Group. In addition, the chairman, chief financial officer and three non-executive directors of Phoenix Medical Group are also owned by China Resources. Following the China CITIC Department after China Resources, he was the executive general manager. In the original management team of the Phoenix Medical Group, six people, including the chairman of the board, have changed positions. As a result, China Resources Medical has laid the personnel foundation for its deep involvement in Phoenix Medical and paved the way for the integration of future platform resources. According to the previous transaction announcement, Phoenix Medical will be included in the package. China Resources's expectation is to build it into an important platform for China Resources's health industry. [ Original reading ]

"Nature" pointed out that NgAgo could not be genetically edited: the investigation was completed in January next year.

After controversy over the reproducibility of the NgAgo experiment of Hebei University of Science and Technology Han Chunyu for half a year, the paper published "Natural-Biotechnology" (NBT) finally issued a statement saying that it was published today by Toni Cathomen and colleagues ( Editor's Note: The communication article of the research team of the United States, Germany and South Korea may deny the main finding of Han Chunyu's original paper on the effective editing of endogenous genes. If a paper is criticized after its publication, NBT will conduct a prudent and comprehensive assessment of various criticisms, and it will complete the investigation of Han Chunyu's NgAgo experiment by the end of January 2017. [ Original reading ]

Veterinary Drugs

Veterinary drugs constitute a large group of compounds, it includes antibiotics, anthelmintics, hormones and nonsteroidal antiinflammatory drugs (NSAIDs) among others. They are used to treat sick animals but also as growth promoters in healthy individuals

New Animal Drug;Veterinary Products;Veterinary Medicine;Veterinary Medicine Drugs,Veterinary Drug Material

Taizhou Volsen Chemical Co., Ltd. , https://www.volsenchem.com